Table 3.
Mean Acute Physiology and Chronic Health Evaluation III Scores of Patients Who Received Organ Supports
| Vital Organ Support | Mean APACHE III of Women Receiving Vital Organ Support | Mean APACHE III of Men Receiving Organ Support | Absolute Difference in Mean APACHE III Score, Women Compared to Men (99% CI) |
|---|---|---|---|
| Invasive ventilation (n = 697,785) | 60.8 (27.3) | 58.6 (26.6) | 2.2 (1.9-2.5) |
| Noninvasive ventilation (n = 583,077) | 59 (23.2) | 60.1 (23.7) | -1.1 (-1.6 to -0.6) |
| Vasoactive medication (n = 587,709) | 62.9 (25.9) | 62.5 (25.6) | 0.4 (0.05-0.6) |
| Renal replacement therapy (n = 575,376) | 87 (28.6) | 86.9 (27.9) | 0.1 (-0.9-1.1) |
| Extracorporeal membrane oxygenation (n = 574,751) | 78.7 (32.5) | 84.3 (33.7) | -5.6 (-10.1 to -1) |
| Any vital organ support (n = 609,329) | 59.5 (25.2) | 59.1 (25.2) | 0.4 (0.2-0.7) |
APACHE = Acute Physiology and Chronic Health Evaluation, n = patients with complete data for each organ support.
Data are presented as number and percentage of patients, mean with sd, absolute difference in means (99% CI), or odds ratios (99% CI) (see Table E2, http://links.lww.com/CCM/H424, for further details).